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The permeability barrier of hairless mouse skin has been 
determined in vitro after exposure of the epidermal surface to 
volumes of acetone typically used in human in vivo skin 
penetration studies. It has been shown that the transport of 
tritiated water (when applied for limited 5-h periods) across 
hairless mouse skin is not affected by acetone treatments of 
approximately 15 J.ll/cm2. Submersion of the membranes be-
tween aqueous donor and receptor phases for periods greater 
than 24 h, however, leads to significant and catastrophic bar-
rier impairment. The acetone dose in the experiments re-
ported is greater than that employed in vivo when the solvent 
T he use of animal skin in the study of percutaneous absorption has provided fundamental knowledge toward our understanding of barrier function . There are important differences, however, in the permeabil-ities of skin taken from different species and these 
inconsistencies have been highlighted in a number of publications 
[1 - 4] . Currently, there is considerable activity in the area of in vitro 
skin permeation measurement. At least three major driving forces 
for this effort can be identified: 1) The U.S. Food and Drug Admin-
istration recently sponsored a workshop on in vitro methods for the 
purpose of establishing guidelines that could be followed when new 
topical drug formulations are under development [5]. 2) There is a 
continuing need for reliable, and meaningful, procedures that can be 
used to predict the health risk resulting from dermal exposure to 
toxic substances [6] . 3) The emergence of trans dermal drug delivery 
to provide systemic pharmacologic effect has introduced percutane-
ous penetration measurement as a key component of the pharma-
ceutic research and development effort [7] . 
The heightened interest in assessing percutaneous transport has 
led several investigators to use substitutes for human skin. It is 
sometimes difficult to obtain human tissue in a regular or timely 
fashion; in addition, the high level of variability associated with 
cadaver skin [8] has frustrated researchers and has directed them to 
consider alternatives. Of the various models that have been studied 
the skin of the hairless mouse is probably the mostropular. There is 
no doubt that this tissue has enabled a number 0 key studies that 
have greatly increased our understanding of the skin permeation 
process. For example, it has allowed fundamental research into 
structure - penetration relationships [9 - 12], concurrent transport 
and metabolism [13 - 16), and the effects of skin damage on barrier 
Manuscript received June 21 , 1988; accepted for publication January 6, 
1989. 
This work was supported by National Institutes of Health grants 
GM-33395 and HD-23010 and by the U.S. Environmental Protection 
Agency through cooperative agreement, CR-812474. 
Reprint requests to: Dr. R. H. Guy, School of Pharmacy, University of 
California, San Francisco, CA 94143-0446. 
is used to deposit a penetrant on human skin. We suggest, 
therefore, that acetone-mediated facilitation of percutaneous 
absorption in humans is unlikely. A further conclusion of this 
work is that in vitro solvent-deposition penetration experi-
ments using hairless mouse skin should provide reliable 
transport information for at least 48 h postadrninistration. 
Although hairless mouse skin is more permeable than its 
human counterpart, in vitro measurements using the murine 
barrier should, therefore, provide useful and relevant guide-
lines for risk assessment calculations and bioavailability 
determinations.] Invest DermatoI93:87 - 91 , 1989 
function [17 - 19] . The advantages of hairless mouse skin include its 
availability and reproducibility. It is more permeable than human 
skin, too, and this is an asset for both bioavailability and risk assess-
ment, as a result obtained with hairless mouse skin will err on the 
conservative side. In risk assessment, for instance, a permeation 
measurement through hairless mouse skin will not lead to an under-
estimate of dermal exposure in humans. This higher permeability, 
however, is also considered by some to be a major disadvantage of 
the tissue, although there is little evidence to document this con-
cern. A more serious question, though, pertains to the response of 
hairless mouse skin, relative to that of human skin, to situations or 
circumstances often encountered in percutaneous penetration work, 
e.g., the effect of hydration and of organic solvents. The hydration 
issue was recently addressed by Bond and Barry [20), who showed 
that prolonged exposure of hairless mouse skin to aqueous donor 
and receptor phases in simple diffusion cells caused considerable 
derangement of barrier function. The interests of our laboratory 
have centered on in vivo evaluation of rercutaneous absorption 
[21 - 25] . Typically, topical application 0 chemicals has involved 
deposition from an organic solvent, usually acetone. The question 
posed by the research presented here, therefore, was: "Does the 
amount of acetone used as the vehicle in human skin penetration 
srudies cause significant changes to the barrier function of hairless 
mouse skin in vitro?" A negative response would imply that 1) 
human skin in vivo is not damaged by the acetone deposition and 
delivery process and 2) in vitro hairless mouse skin experiments 
involving chemical application in acetone may provide information 
relevant to percutaneous absorption in humans. 
MATERIALS AND METHODS 
To assess barrier function status of hairless mouse skin, the perme-
ability of tritiated water (3H20, 0.05 ).lCi/ml, New England Nu-
clear, Boston, MA) was determined at designated times after various 
acetone treatments. Permeation experiments were performed in 
conventional flow-through diffusion cells (Laboratory Glass Appa-
ratus, Berkeley, CA) [26] . The area of skin exposed was 3 .14 cm2; 
the volume of the receptor phase was approximately 5 cm3 • The 
flow-rate was adjusted by a cassette pump (Manostat, New York, 
0022-202X/89/S03.50 Copyright © 1989 by The Society for IilVestigative Dermatology, Inc. 
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NY) so that the receptor solution was completely exchanged in 1 h. 
The receptor phase was normal saline in phosphate buffer at pH 7.4. 
Perfusate was collected in test tubes mounted on a fraction collector 
(Gilson FC-220, Middleton, WI) and the samples were then ana-
lyzed by liquid scintillation counting (Searle Mark III Model 6880, 
Elk Grove, IL). The diffusion cells were thermostatted at 35 ° C 
throughout the experiments; under these conditions, with the skin 
open to the laboratory atomosphere, the surface temperature of the 
membrane was 32°C ± 1°C. 
In all experiments, full-thickness skin from hairless mice (HRS/ 
hr hr, 6-16 wk, Simonsen Laboratories, Gilroy, CA) was used. The 
skin was removed from the animal immediately after killing, any 
small fatty deposits were carefully removed, and the membrane was 
then mounted in the diffusion cell. Typically, eight diffusion cells 
were used in each experiment, requiring skin from four mice. 
When comparisons were made within a run (acetone treatment vs. 
no treatment, for example), the four skins were halved so that each 
animal contributed to both the "control" and "test" set of cells. 
Because of the time involved in setting up eight diffusion cells and 
adjusting the receptor solution flow-rate appropriately, an experi-
ment was typically started within 2 h after killing of the animals. 
The experiments performed are summarized in Table I. The de-
sign was selected to test the effects of an acetone dose on barrier 
function and tissue constancy. The water treatments involved appli-
cation of 1 cm3 oPH20 to the skin surface. To prevent evaporation, 
the upper half of the diffusion cell was then covered until the water 
was removed. Whenever water was not in contact with the skin, the 
surface was open to ambient conditions. Acetone treatments in-
volved application of 50 .ul of the solvent by a capillary pipet. As 
peformed in vivo, the acetone was distributed evenly over the skin 
surface, which, again, was open to the laboratory atmosphere. 
When water was administered subsequent to acetone treatment (ex-
periments Ilia, IVa, V) there was a 2- to 3-min time lapse between 
solvent applications. No liquid acetone remained at this point. 
Experiments I and II simply determined water permeation over 
24- and 48-h periods, in the absence of acetone treatment. Experi-
ments III and IV used short 5-h exposures of the tissue to water and 
assessed the long-term consequences of an acetone dose at t = O. 
Experiment V involved a greater potential insult to the tissue and 
included three volatile solvent treatments. Experiment VI consid-
ered the effect of a time delay postacetone application followed by 
prolonged water contact. 
RESULTS 
In experiments I and II, the skin remained sandwiched between 
aqueous solutions throughout the measurement periods (24 and 48 
h, respectively) . Figure 1 shows that in experiment I, 3H20 flux is 
essentially constant over the 3- to 20-h postapplication period, cor-
responding to a permeability coefficient of about 2.95 X 10-3 cm/h 
(in good agreement with recently published data [20]). Increased 
permeation, however, is suggested by the later time points, an infer-
ence confirmed by experiment II. Figure 2 indicates that prolonged 
and complete hydration leads to barrier breakdown after 24 h of 
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Figure 1. Permeation (mean flux ± SD, n = 8) of 3H20 through hairless 
mouse skin when the membrane is sandwiched between aqueous solutions 
for 24 h (experiment I) . 
contact. Indeed, in six out of eight cells, the membrane has been so 
damaged that 3H20 flux decreases at later times due to the substan-
tial depletion of radiolabel in the donor phase. 
The results of experiments III and IV are summarized in Figures 3 
and 4, respectively. It is apparent that when water is dosed intermit-
tently to the skin surface for 5-h periods, pretreatment with acetone 
does not cause any significant difference to the permeability behav-
ior. This conclusion was substantiated by statistical comparisons 
(paired Wilcoxon and Student's t-tests) of the cumulative amounts 
of water transported across the control and acetone-treated mem-
branes, following the 5-h applications. Acetone elicited an insignifi-
cant effect (0: > 0.2, p > 0.1) on water permeation. Figure 5, which 
contains the data from experiment V, demonstrates that repeated 
acetone administration before dosing with water also elicits no sig-
nificant derangement of barrier function. Although Figures 3, 4, 
and 5 appear to suggest that, regardless of acetone treatment or not, 
the permeability oPH20 increases with time, the trend is not statis-
tically significant. It is perhaps reasonable, however, to conclude 
that hydration and the detrimental effects thereof, can continue 
during the water "off" periods. 
Finally, Figure 6 iliusrrates the results of experiment VI, in which 
the permeation oPH20 was followed 24 h after acetone treatment. 
Again, no difference from the control studies was observed al-
Table I. Experimental Design Summary (n = number of replicates) 
Experiment n Treatments 
I 8 ! t 
II 8 ~ i 
lIla 8 *! t ! t 
IIIb 8 ! t ! i 
IVa 12 *~ t ~ t ~ t 
IVb 16 ! t ! t ! t 
V 4 *! t *! t *~ t 
VIa 12 ! t 
VIb 12 ! t 
0 4 8 12 16 20 24 28 32 36 40 44 48 52 56 
Time (hours) 
• - 50 Jll acetone; ~ - water on; t - water off 
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Figure 2. Permeation of 3HzO through hairless mouse skin when the 
membrane is sandwiched between aqueous solutions for 48 h (experiment 
II). The results from eight separate experiments are shown. The average 
3HzO permeability coefficient during the 5 - 15-h postdosing period is 
1.27 X 10- 3 cm/h. 
though. as before, prolonged exposure to aqueous solutions did 
begin to compromise the skin. 
DISCUSSION 
The experiments performed in this investigation lead to two imJ>or-
tant conclusions. First, as recently reported by Bond and Barry [20]. 
the barrier function of hairless mouse skin does not withstand pro-
longed submersion in aqueous solution. The data in Figures 1 and 2 
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Figure 3. Effect of acetone pretreatment (15 p.ljcmZ) on tritiated water flux 
(mean ± SO. n = 8) across hairless mouse skin after applications from 
t = 0 - 5 hand t = 24 - 29 h (experiment III) . 
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Figure 4. Effect of acetone pretreatment (15 p.lfcmZ) on tritiated water flux 
(mean ± SO, n ~ 12) across hairless mouse skin after applications from t = 
0 - 5 h, t = 24 - 29 h. and t = 48 - 53 h (experiment IV). 
clearly reveal that exposure of the tissue to aqueous solutions, in 
both donor and receiver compartments. for periods in excess of24 h, 
leads to substantial degeneration of the stratum corneum. The sec-
ond key finding revealed by this study is that treatment of hairless 
mouse skin with acetone, in a fashion that mimics a typical "sol-
vent-deposition" application procedure [22 - 25] does not appear to 
alter permanently the barrier to water to any significant degree. The 
results of experiments III, IV. and V indicate that acetone adminis-
tration per se does not contribute to derangement of the stratum 
corntum. The data also suggest that if a penetrant were delivered in 
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Figure 5. Tritiated water flux (mean ± SO. n = 4) across hairless mouse 
skin after applications from (=0 - 5 h. ( = 24 - 29 h. and t= 48 - 53 h. Before 
eMir administration of water, the skin was pretreated with acetone at a dose of 
15 p.1/cmz. 
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Figure 6. Permeation (mean flux ± SD, n = 12) oPH20 through hairless 
mouse skin 24 h after mounting the membrane in the diffusion cell, and after 
treating the "acetone" specimens with a solvent dose of 15 )J.l/cm2• For the 
subsequent 24-h period of observation presented here, the skin is sand-
wiched between aqueous donor and receptor phases (experiment VI). Based 
on the essentially constant 3H20 fluxes between 5 and 10 h, permeability 
coefficients for the control and acetone-treated membranes are calculated to 
be 1.88 X 10- 3 cm/h and 1.83 X 10-3 cm/h, respectively. 
an acetone vehicle under similar circumstances, one may expect the 
barrier function of hairless mouse skin to remain reasonably con-
stant for at least 48 h. The short 5-h 3H20 applications were de-
signed to test the skin permeability while minimizing hydration 
effects. In this respect, they would appear to have fulfilled their 
function adequately. Experiment V challenged the tissue further by 
considering multiple acetone treatments. Again, however, no sig-
nificant effect of the solvent, over that observed in the controls 
(experiment IVb), was apparent. Furthermore, experiment VI 
showed that air-exposure of the epidermal surface for 24 h (acetone 
pretreated or not) did not significantly alter subsequent 3H20 per-
meation compared with the "control" , i.e., experiment 1. 
One ramification of our research is that the warning of Bond and 
Barry [20], that " ... hairless mouse skin should not be 
used . . . in . . . permeation studies incorporating long-term 
hydration, as erroneous results can be expected after ... 3 days," 
appears somewhat conservative. On the basis of our data, we would 
be reluctant to draw conclusions from any flux measurements made 
after 24 h submersion. More important, though, we have shown 
that administration of acetone, at a dose of approximately 15 J1.1j 
cm2, does not appear to alter significantly the stratum corneum 
barrier function of hairless mouse skin. Given that a typical topical 
dose of acetone in a solvent-deposition, human in vivo skin penetra-
tion study is less than 10 J1.1/cm2 [22 -25], it seems reasonable to 
suggest that no acetone-mediated facilitation of transport will be 
evident. In addition, one may also deduce that an in vitro penetra-
tion study using hairless mouse skin and solvent-deposition of pene-
trant from acetone (at a dose of 15 J1.1/ cm2 or less) , should provide a 
reasonable model experiment for the in vivo situation. We recog-
nize, however, that the latter two conclusions are based on observa-
tions that use water as the model permeant. It remains to be seen 
whether these deductions are sustained when the penetating mole-
cule is lipophilic in character. Finally, although hairless mouse skin 
is generally more permeable than its human counterpart [20] , the 
application of small volatile solvent volumes does not appear to 
place the murine barrier under measurable stress. The effects of 
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
larger volumes of solvent or of more structurally destructive chemi-
cals (e.g., penetration enhancers) [27] will, no doubt, be greater and 
may be amplified in the less substantial stratum corneum of the 
hairless mouse. 
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